An Analysis of N-Acetylcysteine Treatment for Acetaminophen Overdose Using a Systems Model of Drug-Induced Liver Injury

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2012-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1124/jpet.112.192930PMID 22593093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure

  2012cited by this paper
• Liver regeneration.

  2012cited by this paper
• Evaluation of specific metabolic rates of major organs and tissues: Comparison between men and women

  2011cited by this paper
• The effects of physiological adaptations to calorie restriction on global cell proliferation rates.

  2011cited by this paper
• Protective effects of exogenous glutathione and related thiol compounds against drug-induced liver injury.

  2011cited by this paper
• Insulin resistance induced by a high-fructose diet potentiates thioacetamide hepatotoxicity.

  2010cited by this paper
• When do the aminotransferases rise after acute acetaminophen overdose?

  2010cited by this paper
• Arjunolic acid, a triterpenoid saponin, prevents acetaminophen (APAP)-induced liver and hepatocyte injury via the inhibition of APAP bioactivation and JNK-mediated mitochondrial protection.

  2010cited by this paper
• Acetaminophen-induced cytotoxicity on human normal liver L-02 cells and the protection of antioxidants

  2010cited by this paper
• IV versus oral acetylcysteine.

  2010cited by this paper
• Insulin resistance induced by high-fructose diet potentiates carbon tetrachloride hepatotoxicity

  2010cited by this paper
• Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays

  2010cited by this paper
• Silencing Glycogen Synthase Kinase-3β Inhibits Acetaminophen Hepatotoxicity and Attenuates JNK Activation and Loss of Glutamate Cysteine Ligase and Myeloid Cell Leukemia Sequence 1*

  2010cited by this paper
• Relationship Between Basal Metabolic Rate, Gender, Age, and Body Composition in 8,780 White Obese Subjects

  2010cited by this paper
• Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N‐acetylcysteine

  2010cited by this paper
• Reactive nitrogen species in acetaminophen-induced mitochondrial damage and toxicity in mouse hepatocytes.

  2010cited by this paper
• Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen Consumption

  2010cited by this paper
• Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas.

  2010cited by this paper
• Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo

  2009cited by this paper
• Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose.

  2009cited by this paper
• Sensitivity of Liver Injury in Heterozygous Sod2 Knockout Mice Treated with Troglitazone or Acetaminophen

  2009cited by this paper
• Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose.

  2009cited by this paper
• Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning.

  2009cited by this paper
• Protection of acetaminophen induced mitochondrial dysfunctions and hepatic necrosis via Akt-NF-kappaB pathway: role of a novel plant protein.

  2009cited by this paper
• Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose.

  2009cited by this paper
• Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity

  2009cited by this paper
• Bacterial- and Viral-Induced Inflammation Increases Sensitivity to Acetaminophen Hepatotoxicity

  2009cited by this paper
• A retrospective evaluation of shortened-duration oral N-acetylcysteine for the treatment of acetaminophen poisoning

  2009cited by this paper
• N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes.

  2009cited by this paper
• Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate without affecting red blood cell or plasma glutathione concentrations in healthy men and women.

  2009cited by this paper
• Glutathione in liver diseases and hepatotoxicity.

  2009cited by this paper
• Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats

  2009cited by this paper
• Oxidative stress induces a reversible flux of cysteine from tissues to blood in vivo in the rat

  2009cited by this paper
• IV versus oral N-acetylcysteine.

  2009cited by this paper
• Prolonged N-acetylcysteine therapy in late acetaminophen poisoning associated with acute liver failure – a need to be more cautious?

  2009cited by this paper
• Estimated risk of hepatotoxicity after an acute acetaminophen overdose in alcoholics.

  2008cited by this paper
• Acetaminophen‐Associated Hepatic Injury: Evaluation of Acetaminophen Protein Adducts in Children and Adolescents With Acetaminophen Overdose

  2008cited by this paper
• Muscular exercise can cause highly pathological liver function tests in healthy men.

  2008cited by this paper
• Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function.

  2008cited by this paper
• Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation.

  2008cited by this paper
• Propolis reverses acetaminophen induced acute hepatorenal alterations: A biochemical and histopathological approach

  2008cited by this paper
• Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes.

  2008cited by this paper
• Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice.

  2008cited by this paper
• Role of JNK Translocation to Mitochondria Leading to Inhibition of Mitochondria Bioenergetics in Acetaminophen-induced Liver Injury*

  2008cited by this paper
• Innate immunity and acetaminophen‐induced liver injury: Why so many controversies?

  2008cited by this paper
• Frequency of Medication Errors with Intravenous Acetylcysteine for Acetaminophen Overdose

  2008cited by this paper
• Red blood cells as a physiological source of glutathione for extracellular fluids.

  2008cited by this paper
• Acetylcysteine for acetaminophen poisoning.

  2008cited by this paper
• Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2.

  2008cited by this paper
• Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group

  2007cited by this paper
• Effect of acetaminophen administration to rats chronically exposed to depleted uranium.

  2007cited by this paper
• Safety and efficacy of intravenous N‐acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database

  2007cited by this paper
• Isoforms of alanine aminotransferases in human tissues and serum--differential tissue expression using novel antibodies.

  2007cited by this paper
• Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease

  2007cited by this paper
• Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements

  2006cited by this paper
• The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death

  2006cited by this paper
• Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure

  2006cited by this paper
• Mitochondrial glutathione: Hepatocellular survival–death switch

  2006cited by this paper
• Neutrophil depletion protects against murine acetaminophen hepatotoxicity

  2006cited by this paper
• Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study

  2006cited by this paper
• Numerical investigation of non-Newtonian microcirculatory blood flow in hepatic lobule.

  2006cited by this paper
• c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity.

  2006cited by this paper
• Distinct roles of NF-kappaB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity.

  2006cited by this paper
• Modeling inflammation-drug interactions in vitro: a rat Kupffer cell-hepatocyte coculture system.

  2006cited by this paper
• The administration of N-acetylcysteine causes a decrease in prothrombin time in patients with paracetamol overdose but without evidence of liver impairment

  2005cited by this paper
• Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride.

  2005cited by this paper
• Calpain: a death protein that mediates progression of liver injury.

  2005cited by this paper
• Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study

  2005cited by this paper
• Role of membrane transport in metabolism and function of glutathione in mammals

  2005cited by this paper
• Tissue Repair: An Important Determinant of Final Outcome of Toxicant-Induced Injury

  2005cited by this paper
• A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication.

  2005cited by this paper
• Role of glutathione transport processes in kidney function.

  2005cited by this paper
• A New Predictor of Toxicity Following Acetaminophen Overdose Based on Pretreatment Exposure

  2005cited by this paper
• Peroxynitrite-Induced Mitochondrial and Endonuclease-Mediated Nuclear DNA Damage in Acetaminophen Hepatotoxicity

  2005cited by this paper
• Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine

  2004cited by this paper
• The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage

  2004cited by this paper
• Pharmacokinetics of N-acetylcysteine in man

  2004cited by this paper
• Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine.

  2004cited by this paper
• Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration

  2004cited by this paper
• Potentiation of Carbon Tetrachloride Hepatotoxicity and Lethality in Type 2 Diabetic Rats

  2004cited by this paper
• Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity.

  2004cited by this paper
• Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid.

  2004cited by this paper
• Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease

  2004cited by this paper
• Acetaminophen Intoxication and Length of Treatment: How Long Is Long Enough?

  2003cited by this paper
• Paracetamol poisoning: which nomogram should we use?

  2003cited by this paper
• Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants.

  2003cited by this paper
• Acetaminophen Toxicity in Mice Lacking NADPH Oxidase Activity: Role of Peroxynitrite Formation and Mitochondrial Oxidant Stress

  2003cited by this paper
• Protection against acetaminophen‐induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase

  2002cited by this paper
• Peroxynitrite Is a Critical Mediator of Acetaminophen Hepatotoxicity in Murine Livers: Protection by Glutathione

  2002cited by this paper
• Protective effect of moutan cortex extract on acetaminophen-induced cytotoxicity in human Chang liver cells.

  2002cited by this paper
• Acetaminophen hepatotoxicity and mechanisms of its protection by N-acetylcysteine: a study of Hep3B cells.

  2002cited by this paper
• Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury.

  2002cited by this paper
• Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.

  2002cited by this paper
• Regenerative activity and liver function following partial hepatectomy in the rat using 31P‐MR spectroscopy

  2002cited by this paper
• Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

  2002cited by this paper
• Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model.

  2001cited by this paper
• High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes.

  2001cited by this paper
• An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen

  2001cited by this paper
• Autoprotection in acetaminophen intoxication in rats: the role of liver regeneration.

  2001cited by this paper
• Acetaminophen-induced hepatotoxicity in mice lacking inducible nitric oxide synthase activity.

  2001cited by this paper

• A Proxy-guided Workflow for Virtual Population Development

  2025cites this paper
• Modeling and Simulation of Acetaminophen Pharmacokinetics and Hepatic Biomarkers After Overdoses of Extended‐Release and Immediate‐Release Formulations in Healthy Adults Using the Quantitative Systems Toxicology Software Platform DILIsym

  2025cites this paper
• Quantitative Systems Toxicology Modeling of Acetaminophen Pharmacokinetics and Hepatic Biomarkers After Overdoses of Extended‐Release and Immediate‐Release Formulations in Adults With Chronic Alcohol Use or Low Glutathione

  2025cites this paper
• Mechanism and marker of voriconazole-induced liver injury: insights from a quantitative systems toxicology approach.

  2025cites this paper
• Quantitative Approaches to Accelerate MASH Drug Discovery and Development

  2025cites this paper
• Development of a Novel In Silico Classification Model to Assess Reactive Metabolite Formation in the Cysteine Trapping Assay and Investigation of Important Substructures

  2024cites this paper
• Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition

  2023cites this paper
• The Combination of a Human Biomimetic Liver Microphysiology System with BIOLOGXsym, a Quantitative Systems Toxicology (QST) Modeling Platform for Macromolecules, Provides Mechanistic Understanding of Tocilizumab- and GGF2-Induced Liver Injury

  2023cites this paper
• Assessing Liver Effects of Cannabidiol and Valproate Alone and in Combination Using Quantitative Systems Toxicology

  2023cites this paper
• Unraveling the effect of intra- and intercellular processes on acetaminophen-induced liver injury

  2022cites this paper
• Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application

  2022cites this paper
• Unraveling the effect of intra- and intercellular processes on acetaminophen-induced liver injury

  2022cites this paper
• Applications of In Silico Models to Predict Drug-Induced Liver Injury

  2022cites this paper
• Quantitative Systems Toxicology and Drug Development: The DILIsym Experience.

  2022cites this paper
• Evaluation of the hepatoprotective effect of curcumin-loaded solid lipid nanoparticles against paracetamol overdose toxicity: Role of inducible nitric oxide synthase

  2022cites this paper
• Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278.

  2022cites this paper
• [Mixed steatohepatitis: more questions than answers (part 2)].

  2021cites this paper
• Comprehensive Investigation Evaluating the Carcinogenic Hazard Potential of Acetaminophen.

  2021cites this paper
• Effect of different doses of acetaminophen through drinking water on body organs and serum biochemical parameters in broilers

  2021cites this paper
• Virtual Populations for Quantitative Systems Pharmacology Models.

  2021cites this paper
• Review of applications and challenges of quantitative systems pharmacology modeling and machine learning for heart failure

  2021cites this paper
• Cost of inappropriate use of intravenous N-acetylcysteine for acetaminophen toxicity

  2021cites this paper
• Herbal Therapy for the Treatment of Acetaminophen-Associated Liver Injury: Recent Advances and Future Perspectives

  2020cites this paper
• A critical review of the acetaminophen preclinical carcinogenicity and tumor promotion data and their implications for its carcinogenic hazard potential.

  2020cites this paper
• Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym

  2020cites this paper
• Quantitative Systems Toxicology Approaches to Understand and Predict Drug-Induced Liver Injury.

  2020cites this paper
• Orostachys japonicus ameliorates acetaminophen-induced acute liver injury in mice.

  2020cites this paper
• Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophen.

  2020cites this paper
• Drug-induced liver injury in cancer patients

  2020cites this paper
• Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)

  2019cites this paper
• Analyzing the Mechanisms Behind Macrolide Antibiotic-Induced Liver Injury Using Quantitative Systems Toxicology Modeling

  2019cites this paper
• The DILI‐sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation

  2019cites this paper
• Acetaminophen

  2019cites this paper
• N-acetylcysteine for adults with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials

  2019cites this paper
• Лекарственные поражения печени (клинические рекомендации для врачей)

  2019cites this paper
• Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury

  2019cites this paper
• Quantitative systems toxicology (QST) reproduces species differences in PF‐04895162 liver safety due to combined mitochondrial and bile acid toxicity

  2019cites this paper
• Colchicine and Cysteine in the management of Paracetamol- induced Liver damage

  2019cites this paper
• Enhancement of Colchicine in the Management of Paracetamol- Induced Hepatotoxicity with Cysteine and Vitamine E

  2019cites this paper
• A systems toxicology framework for improving the identification of paracetamol overdose

  2019cites this paper
• Using Quantitative Systems Toxicology to Investigate Observed Species Differences in CKA-Mediated Hepatotoxicity

  2018cites this paper
• An Introduction to DILIsym ® Software, a Mechanistic Mathematical Representation of Drug-Induced Liver Injury

  2018cites this paper
• Extrapolation of In Vitro Results to Predict Human Toxicity

  2018cites this paper
• Chapter 190 : Acetaminophen

  2018cites this paper
• Acetaminophen Poisoning: A Case Based Approach.

  2018cites this paper
• Prediction of Safety Margin and Optimization of Dosing Protocol for a Novel Antibiotic using Quantitative Systems Pharmacology Modeling

  2018cites this paper
• Quantitative Systems Toxicology Analysis of In Vitro Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury

  2018cites this paper
• Novel Regimens in the Treatment of Paracetamol (Acetaminophen) Poisoning.

  2017cites this paper
• Intravenous N-Acetylcysteine for Acetaminophen Toxicity.

  2017cites this paper
• Systems pharmacology modeling of drug‐induced hyperbilirubinemia: Differentiating hepatotoxicity and inhibition of enzymes/transporters

  2017cites this paper
• A model qualification method for mechanistic physiological QSP models to support model‐informed drug development

  2016cites this paper
• Evaluation of a new benzothiazole derivative with antioxidant activity in the initial phase of acetaminophen toxicity

  2016cites this paper
• Development of quantitative systems pharmacology and toxicology models within consortia: experiences and lessons learned through DILIsym development

  2016cites this paper
• Elucidating Differences in the Hepatotoxic Potential of Tolcapone and Entacapone With DILIsym®, a Mechanistic Model of Drug‐Induced Liver Injury

  2016cites this paper
• Acetaminophen-induced Liver Injury: Characterization of Infiltrating Macrophages and CX3CR1 Associated Recruitment

  2016cites this paper
• Drug Toxicities of Common Analgesic Medications in the Emergency Department.

  2016cites this paper
• Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors

  2016cites this paper
• Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.

  2016cites this paper
• Pathways involved in acetaminophen hepatotoxicity with specific targets for inhibition/downregulation

  2015cites this paper
• Drug-induced liver injury: Diagnosing (and treating) it early.

  2015cites this paper
• Antioxidant and hepatoprotective activity of vitex honey against paracetamol induced liver damage in mice.

  2015cites this paper
• A quantum chemical study of the reactivity of acetaminophen (paracetamol) toxic metabolite N-acetyl-p-benzoquinone imine with deoxyguanosine and glutathione.

  2015cites this paper
• Mechanistic Modeling of Drug-Induced Liver Injury (DILI)

  2015cites this paper
• The Emerging Discipline of Quantitative Systems Pharmacology

  2015influential citation
• Comparing the Therapeutic Effectiveness of N-acetylcysteine with the Combination of N-acetyl Cysteine and Cimetidine in Acute Acetaminophen Toxicity: A Double-Blinded Clinical Trial

  2015cites this paper
• An Update on Treatment of Drug-Induced Liver Injury

  2014cites this paper
• A Mechanistic Model of Drug-Induced Liver Injury Aids the Interpretation of Elevated Liver Transaminase Levels in a Phase I Clinical Trial

  2014cites this paper
• Systems Pharmacology Modeling Predicts Delayed Presentation and Species Differences in Bile Acid-Mediated Troglitazone Hepatotoxicity

  2014cites this paper
• A single-arm clinical trial of a 48-hour intravenous N-acetylcysteine protocol for treatment of acetaminophen poisoning

  2014cites this paper
• Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury

  2014cites this paper
• Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid–Mediated DILI

  2014cites this paper
• Computer-based prediction of the drug proarrhythmic effect: problems, issues, known and suspected challenges.

  2014cites this paper
• Linking physiology to toxicity using DILIsym®, a mechanistic mathematical model of drug-induced liver injury.

  2014cites this paper
• The effect of glutathione on 2-hydroxyethylmethacrylate cytotoxicity and on resin-dentine bond strength.

  2014cites this paper
• Evaluation of three-dimensional cultured HepG2 cells in a nano culture plate system: an in vitro human model of acetaminophen hepatotoxicity.

  2014cites this paper
• Use of a systems model of drug-induced liver injury (DILIsym(®)) to elucidate the mechanistic differences between acetaminophen and its less-toxic isomer, AMAP, in mice.

  2014cites this paper
• Evaluation of simple in vitro to in vivo extrapolation approaches for environmental compounds.

  2014cites this paper
• Curcumin and Liver Disease: from Chemistry to Medicine.

  2014cites this paper
• Computational Translation and Integration of Test Data to Meet Risk Assessment Goals

  2013cites this paper
• Urinary protein profiling of drug-induced liver injury: Search for biomarkers and mechanisms

  2013cites this paper
• Biomarkers of drug-induced liver injury

  2013cites this paper
• Predictive computational toxicology to support drug safety assessment.

  2013cites this paper
• Alternate virtual populations elucidate the type I interferon signature predictive of the response to rituximab in rheumatoid arthritis

  2013influential citation
• New Therapeutic Approach: Diphenyl Diselenide Reduces Mitochondrial Dysfunction in Acetaminophen-Induced Acute Liver Failure

  2013cites this paper
• Modeling Drug- and Chemical-Induced Hepatotoxicity with Systems Biology Approaches

  2012cites this paper